Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
Duke Cancer Institute · Hospital Universitari i Politècnic La Fe · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
352
total citations
- FWCI
- 97.78
- Percentile
- 100%
- References
- 41
Citations per year
Authors
22- HPHarry P. ErbaCorresponding
Duke Cancer Institute
- PMPau Montesinos
Hospital Universitari i Politècnic La Fe
- HKHee‐Je Kim
Catholic University of Korea, Seoul St. Mary's Hospital
- EPElżbieta Patkowska
Instytut Hematologii i Transfuzjologi
- RVRadovan Vrḫovac
University of Zagreb, University Hospital Centre Zagreb
Topics & keywords
Topics
Keywords
- Medicine
- Idarubicin
- Placebo
- Internal medicine
- Cytarabine
- Chemotherapy regimen
- Induction chemotherapy
- Regimen
No related works found for this paper.